Skip to main content
Premium Trial:

Request an Annual Quote

NextBio Nets $1M SBIR Grant

NEW YORK (GenomeWeb News) – NextBio has won a Small Business Innovation Research grant to incorporate genomic and proteomic information for vertebrates and plants in its data search and discovery platform, the company said today.

The firm will use the two-year, $1 million grant from the National Institutes of Health to develop the software for searching, discovering, and sharing information found in public and proprietary databases. NextBio will incorporate information from vertebrate organisms and about Arabidopsis, corn, rice, and soy plant genomics in its cross-species platform.

The Cupertino, Calif.-based company said it will develop ontologies, translational methodology, and cross-study comparison tools to connect findings from studies of different organisms, and it will develop new statistical and visualization methods to correlate and interpret the data.

The new information will be added to NextBio's collection of data from human, mouse, rat, fly, worm, and yeast systems.

"Life science researchers use critical biological information from studies of diverse species to make key correlations that help them discover new knowledge about human or plant physiology and disease," NextBio CEO Saeid Akhtari said in a statement.

He said the grant will help the company extend the software to help "researchers leverage a wider range of data from model organisms to better understand biology."

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.